First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary

G. Terhes, E. Urbán, M. Konkoly-Thege, É Székely, J. S. Brazier, E. J. Kuijper, E. Nagy

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A recent Supplement to Clinical Microbiology and Infection entitled 'Infection control measures to limit the spread of C. difficile' pointed out that the incidence of C. difficile -associated diarrhoea (CDAD) has been increasing worldwide, and stressed the importance of research in the fields of epidemiology and infection control [1]. Since 2003, one of the main causes of the increasing prevalence of CDAD has been claimed to be the emergence of PCR ribotype 027/NAP1, which has caused epidemics in North America, the UK, the Netherlands, Belgium and France. The presence of PCR ribotype 027 in Austria, Japan, Ireland, Germany and Switzerland has also been reported recently [2,3]. The majority of publications have emphasized that the presence of this strain is usually associated with more severe symptoms and signs than those associated with the other more common toxin-positive strains [4,5]. Whereas PCR ribotype 027 was present in the population earlier, the majority of the historic strains were fluoroquinolone sensitive [6]. The overuse of antibiotics such as fluoroquinolones may lead to the selection and emergence of resistant strains, and may contribute to the spread of PCR ribotype 027, which is usually resistant to erythromycin. Here, the Eastern European spread of C. difficile PCR ribotype 027 is reported.

Original languageEnglish
Pages (from-to)885-886
Number of pages2
JournalClinical Microbiology and Infection
Volume15
Issue number9
DOIs
Publication statusPublished - 2009

Fingerprint

Ribotyping
Clostridium difficile
Hungary
Diarrhea
Polymerase Chain Reaction
Fluoroquinolones
Infection Control
Austria
Belgium
Erythromycin
North America
Microbiology
Switzerland
Ireland
Netherlands
Signs and Symptoms
France
Germany
Publications
Japan

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary. / Terhes, G.; Urbán, E.; Konkoly-Thege, M.; Székely, É; Brazier, J. S.; Kuijper, E. J.; Nagy, E.

In: Clinical Microbiology and Infection, Vol. 15, No. 9, 2009, p. 885-886.

Research output: Contribution to journalArticle

Terhes, G. ; Urbán, E. ; Konkoly-Thege, M. ; Székely, É ; Brazier, J. S. ; Kuijper, E. J. ; Nagy, E. / First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary. In: Clinical Microbiology and Infection. 2009 ; Vol. 15, No. 9. pp. 885-886.
@article{4e7b0bafcd464dfeb5ced21f0d9dcb59,
title = "First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary",
abstract = "A recent Supplement to Clinical Microbiology and Infection entitled 'Infection control measures to limit the spread of C. difficile' pointed out that the incidence of C. difficile -associated diarrhoea (CDAD) has been increasing worldwide, and stressed the importance of research in the fields of epidemiology and infection control [1]. Since 2003, one of the main causes of the increasing prevalence of CDAD has been claimed to be the emergence of PCR ribotype 027/NAP1, which has caused epidemics in North America, the UK, the Netherlands, Belgium and France. The presence of PCR ribotype 027 in Austria, Japan, Ireland, Germany and Switzerland has also been reported recently [2,3]. The majority of publications have emphasized that the presence of this strain is usually associated with more severe symptoms and signs than those associated with the other more common toxin-positive strains [4,5]. Whereas PCR ribotype 027 was present in the population earlier, the majority of the historic strains were fluoroquinolone sensitive [6]. The overuse of antibiotics such as fluoroquinolones may lead to the selection and emergence of resistant strains, and may contribute to the spread of PCR ribotype 027, which is usually resistant to erythromycin. Here, the Eastern European spread of C. difficile PCR ribotype 027 is reported.",
author = "G. Terhes and E. Urb{\'a}n and M. Konkoly-Thege and {\'E} Sz{\'e}kely and Brazier, {J. S.} and Kuijper, {E. J.} and E. Nagy",
year = "2009",
doi = "10.1111/j.1469-0691.2009.02807.x",
language = "English",
volume = "15",
pages = "885--886",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary

AU - Terhes, G.

AU - Urbán, E.

AU - Konkoly-Thege, M.

AU - Székely, É

AU - Brazier, J. S.

AU - Kuijper, E. J.

AU - Nagy, E.

PY - 2009

Y1 - 2009

N2 - A recent Supplement to Clinical Microbiology and Infection entitled 'Infection control measures to limit the spread of C. difficile' pointed out that the incidence of C. difficile -associated diarrhoea (CDAD) has been increasing worldwide, and stressed the importance of research in the fields of epidemiology and infection control [1]. Since 2003, one of the main causes of the increasing prevalence of CDAD has been claimed to be the emergence of PCR ribotype 027/NAP1, which has caused epidemics in North America, the UK, the Netherlands, Belgium and France. The presence of PCR ribotype 027 in Austria, Japan, Ireland, Germany and Switzerland has also been reported recently [2,3]. The majority of publications have emphasized that the presence of this strain is usually associated with more severe symptoms and signs than those associated with the other more common toxin-positive strains [4,5]. Whereas PCR ribotype 027 was present in the population earlier, the majority of the historic strains were fluoroquinolone sensitive [6]. The overuse of antibiotics such as fluoroquinolones may lead to the selection and emergence of resistant strains, and may contribute to the spread of PCR ribotype 027, which is usually resistant to erythromycin. Here, the Eastern European spread of C. difficile PCR ribotype 027 is reported.

AB - A recent Supplement to Clinical Microbiology and Infection entitled 'Infection control measures to limit the spread of C. difficile' pointed out that the incidence of C. difficile -associated diarrhoea (CDAD) has been increasing worldwide, and stressed the importance of research in the fields of epidemiology and infection control [1]. Since 2003, one of the main causes of the increasing prevalence of CDAD has been claimed to be the emergence of PCR ribotype 027/NAP1, which has caused epidemics in North America, the UK, the Netherlands, Belgium and France. The presence of PCR ribotype 027 in Austria, Japan, Ireland, Germany and Switzerland has also been reported recently [2,3]. The majority of publications have emphasized that the presence of this strain is usually associated with more severe symptoms and signs than those associated with the other more common toxin-positive strains [4,5]. Whereas PCR ribotype 027 was present in the population earlier, the majority of the historic strains were fluoroquinolone sensitive [6]. The overuse of antibiotics such as fluoroquinolones may lead to the selection and emergence of resistant strains, and may contribute to the spread of PCR ribotype 027, which is usually resistant to erythromycin. Here, the Eastern European spread of C. difficile PCR ribotype 027 is reported.

UR - http://www.scopus.com/inward/record.url?scp=69249091018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249091018&partnerID=8YFLogxK

U2 - 10.1111/j.1469-0691.2009.02807.x

DO - 10.1111/j.1469-0691.2009.02807.x

M3 - Article

VL - 15

SP - 885

EP - 886

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 9

ER -